Radiology, Imaging and Immunotherapy in Cancer (ICRIIC-27)

This track will explore the latest innovations in MRI scanning techniques and their applications in cancer diagnosis. Participants will discuss improvements in image resolution and the integration of AI in MRI analysis.

Focusing on the role of CT scans in cancer detection and monitoring, this session will cover advancements in imaging protocols and contrast agents. Experts will share insights on optimizing CT for better diagnostic outcomes.

This track will delve into the use of PET scans in oncology, highlighting its effectiveness in detecting metabolic changes in tumors. Discussions will include the integration of PET with other imaging modalities for enhanced diagnostic accuracy.

Dedicated to the advancements in mammographic techniques, this session will address the latest research in breast cancer detection and screening protocols. Participants will evaluate the impact of new technologies on early diagnosis.

This track will examine the comparative advantages of hybrid imaging systems such as PET-CT and PET-MRI in cancer diagnostics. Experts will discuss clinical applications and the rationale behind choosing one modality over the other.

Focusing on the underlying principles of immunotherapy, this session will explore the rationale for its use in cancer treatment. Participants will discuss the biological mechanisms that enable immune modulation in cancer therapy.

This track will investigate the synergistic effects of combining radiotherapy with immunotherapy in cancer treatment. Experts will present clinical data supporting this integrative approach and its implications for patient outcomes.

This session will review the current standard therapies for various cancer types, focusing on their efficacy and limitations. Participants will engage in discussions about the future directions of cancer treatment protocols.

This track will highlight the critical role of nursing in cancer care, emphasizing innovative practices and patient management strategies. Discussions will include the integration of technology in nursing workflows to enhance patient outcomes.

Focusing on the immune biological properties of human cancer stem cells, this session will explore novel therapeutic strategies targeting these cells. Participants will discuss the implications of stem cell targeting for improving cancer treatment efficacy.

This track will examine the latest advancements in targeting the myeloma microenvironment with immunotherapy. Experts will discuss the application of bite antibodies in solid tumors and their potential in improving treatment outcomes.